Title: Home Page

URL Source: http://www.pierre-fabre.com/

Published Time: Mon, 07 Jul 2025 09:40:11 GMT

Markdown Content:
Pierre Fabre, French pharmaceutical and dermocosmetics group

===============

go to navigationgo to content

Toggle navigation

Welcome to the Pierre Fabre US websitePierre Fabre - Corporate

×

Navigation principale
* Our GroupWho We Are

* Our shareholder scheme
* Our governance
* Our history
* Pierre Fabre in the world
* Pierre Fabre Key figures
* Newsroom

• 
  

  Our brandsOur Areas of Expertise

  
  
  
  
  • Caring for everyday ailments
  
  
  • Caring for chronic diseases
  
  
  • Caring for the skin
  
  
  • Caring for hair
  
  
  
  


• 
  

  Our commitmentsOur Commitments and Responsabilites

  
  
  
  
  • 
    

    Our sustainable development policy

    
    
    
    
    • Protecting biodiversity
    
    
    
    
  
  
  • 
    

    Acting alongside patients

    
    
  
  
  • Acting ethically
  
  
  • Committed to Diversity and Inclusion
  
  
  
  


• 
  

  Innovation and partnershipsOur Main Fields of Innovation and parteners

  
  
  
  
  • 
    

    Our research & development

    
    
    
    
    • Pharmaceutical R&D
    
    
    • Dermo-cosmetics R&D
    
    
    
    
  
  
  • 
    

    360° Innovation

    
    
  
  
  • Partnerships
    
    
    • Business Development
    
    
    • Contract Development & Manufacturing
    
    
    • Discover our partners
    
    
    
    
  
  
  
  


• 
  

  TalentWorking at Pierre Fabre

  
  
  
  
  • Our job opportunities
  
  
  • Internships
  
  
  • Experienced applicants
  
  
  • Build your career
  
  
  • Cultivating quality of life in the workplace
  
  
  • Visit our premises
  
  
  
  

Journalists
* Journalists
* Applicants
* Partners
* Health care professionals

Select country

Pierre Fabre

New ways to care

Discover the group

US Office inauguration

3,1 BN€

Revenue in 2024

219 M€

Invested in R&D

+10 200

Employees

43

Locations

Previous Next

We develop tomorrow's prescription drugs and products with the inexhaustible resources of our imagination. There is no task more exciting than this!

M. Pierre Fabre, founder of the Group

Discover

Our Brands

Our dual expertise - pharmaceutical and dermo-cosmetic - helps us offer a holistic approach to care: prevent, treat and support.

Learn more about our brands

Taking care of your skin, hair and oral health.

Treating cancer

Treating chronic diseases

Treating everyday ailments

Previous Next

Focus on

Our Commitments

Green Mission Pierre Fabre is the eco-socio-responsible commitment from the Pierre Fabre Group, awarded the Committed to CSR by AFNOR Certification at the Exemplary level. Thanks to our conviction and drive, we use sustainable innovation to benefit Nature and People, focusing on 4 issues:

Discover all our commitments

Innovate

Innovatesustainably

Innovate : sustainably by taking our inspiration from nature, thanks to our botanical expertise and the development of eco-extraction

Find out more

Protect

Protect our plant heritage

reduce our environmental footprint, promote organic farming and encourage agro-ecology

Find out more

Respect

Respectthe farmers and harvesterss

We respect the farmers and harvesters we work with, and help develop the regions from which we source our ingredients

Find out more

Guarantee

Guaranteethe quality

of our eco-designed products, and maximize the development of Ecocert Organic certified active ingredients and our ethical practices

Find out more

Looking for a company

that is in line with your values?

Joining the Pierre Fabre Group means entering a company with a history overflowing with values, innovation and expertise for patients and consumers. What are you waiting for? Look at our offers, apply and embark on a human adventure !

Discover our job offers

Our latest

News

Curious to learn more about our news? Get the latest on our brand innovations, our flagship commitments and the highlights of the life of the group

All our news

Strategy ANNUAL REPORT 25 June 2025 The 2025 Annual Report, under the sign of a new energy Find the 2025 annual report (2024 figures) online. We have placed this year’s annual report under the sign of a “new energy” resulting in :  International growth Therapeutic innovations Medical leadership Financial solidity Collective commitment  

Strategy Events 19 June 2025 Pierre Fabre Laboratories Begins Next Chapter in Secaucus, NJ SECAUCUS, NJ (June 18, 2025): Pierre Fabre Laboratories, a global healthcare company originated from France, announces the inauguration of its new US office located on 500 Plaza Drive, in Secaucus, NJ which will host its dermo-cosmetics and medical care subsidiaries. Pierre Fabre is the world’s second-largest dermo-cosmetics manufacturer and a global player in oncology, cell & gene therapy, rare disease and dermatology. This strategic move in the US marks a pivotal moment in the company’s growth strategy, underscoring its strong commitment to advancing in the US in both dermo-cosmetics and medical care. Pierre Fabre Laboratories introduced global dermo-cosmetics brands Avène, Klorane and René Furterer to the US market in the 1990’s. With an ever-growing desire for French dermo-cosmetics, the US dermo-cosmetics business has become a top priority. Building upon their success in oncology and dermatology in Europe and Asia, the company has recently expanded its medical care investments in the US through the creation of a dedicated pharmaceutics unit, Pierre Fabre Pharmaceuticals (PFP). This subsidiary is focused on continuing to deliver breakthrough therapies in rare diseases and oncology to American patient populations with high unmet needs and limited treatment options.

Press release 31 March 2025 Marie-Andrée GAMACHE joins Pierre Fabre Laboratories as CEO of the Medical Care Castres (France), March 31, 2025 – Pierre Fabre Laboratories has announced the appointment of Marie-Andrée Gamache as Chief Executive Officer (CEO) of its Medical Care. In this capacity, Marie-Andrée Gamache joins the Group’s Executive Committee and reports to Eric

Press release 31 October 2024 Fernando Junoy nommé Directeur de la Business Unit Internationale des Laboratoires Pierre Fabre Castres, le 31 octobre 2024 – Les Laboratoires Pierre Fabre annoncent la nomination de Fernando Junoy au poste de Directeur de leur Business Unit Internationale (BUI). À ce titre, il est rattaché à Eric Ducournau, Directeur général, et rejoint le Comité de direction.

Press release 17 May 2024 Pierre Fabre Laboratories Awarded Responsible Digital Label May 16, 2024 – Pierre Fabre Laboratories has been awarded the highest level of the Digital Responsibility label for its commitment to a more environmentally and socially responsible digital industry.

Press release 29 March 2024 Global study on rosacea: 5% of the population affected, according to Pierre Fabre Laboratories. Spotlight on rosacea, which affects 5% of the world population according to the first global epidemiological study of this dermatosis carried out by Pierre Fabre Laboratories.

Press release 19 March 2024 Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne” Published in February 2024 in the Journal of American Academy of Dermatology (JAAD), this study reveals the prevalence of acne worldwide in a completely new light.

Press release 5 March 2024 Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories •    Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.

×

We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.

Get in touch with your local Pierre Fabre branch

InternationalFREN

Europe

• BelgiumFRNL


• Denmark


• Finland


• France


• Germany


• Italia


• Norway


• Poland


• Portugal


• Spain


• Sweden


• SwitzerlandDEFR


• Turkey

America

• Brazil


• Mexico


• United States

Asia

• China

Oceania

• Australia

Main navigation

• Our Group


• Our brands


• Our commitments


• Innovation and partnerships


• Talent

User profiles

• Journalists


• Applicants


• Partners


• Health care professionals

Useful links

• Charters


• Terms & Conditions


• Group websites

Follow us

contact us

Menu Pied de page
* Privacy policy
* Credits
* Legal informations
* Sitemap
* Accessibility

© Pierre Fabre Laboratories 2025

We offer you an experience that suits you thanks to cookies

We use cookies to provide you with better personalization and advanced functionality when using our site. To continue and facilitate your navigation on the site, you can directly accept the use of cookies. Otherwise, you can customize the use of cookies. For more information on the processing of personal data, please see our privacy policy by clicking below:Privacy Policy

Only the essentials OK

Cookies Settings

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

More information

Allow All

Manage Consent Preferences

Strictly Necessary Cookies

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Cookies Details‎

Performance Cookies

• [x] Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Cookies Details‎

Functional Cookies

• [x] Functional Cookies

These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

Cookies Details‎

Targeting Cookies

• [x] Targeting Cookies

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Cookies Details‎

Cookie List

Clear

• [x] checkbox label label

Apply Cancel

Consent Leg.Interest

• 
  

  [x] checkbox label label

  
  


• 
  

  [x] checkbox label label

  
  


• 
  

  [x] checkbox label label

  
  

Reject All Confirm My Choices